Search results

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 17 December 2020

Fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients at risk for heart valve regurgitation (incompetence).

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 21 March 2019

Disabling, long-lasting or potentially irreversible adverse reactions affecting musculoskeletal and nervous systems have been reported very rarely with fluoroquinolone antibiotics. Fluoroquinolone...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 14 November 2018

In patients at risk for aortic aneurysm and dissection, fluoroquinolones should only be used after careful assessment of the benefits and risks and after consideration of other therapeutic options.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 11 December 2014

Further information is available to support safer use

Read Summary

Type:

Safety Alerts (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

29 April 2020

Back to guidelines homepage Assisted Vaginal Birth (Green-top Guideline No. 26) Published: 29/04/2020

Type:

Guidance (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

17 December 2019

Back to guidelines homepage Maternal Collapse in Pregnancy and the Puerperium (Green-top Guideline No. 56) Published: 17/12/2019

Type:

Guidance (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

30 September 2020

Back to guidelines homepage Gestational Trophoblastic Disease (Green-top Guideline No. 38) Published: 30/09/2020

Type:

Guidance (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

18 June 2019

Back to guidelines homepage Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation

Type:

Guidance (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

22 November 2018

Back to guidelines homepage Care of Women with Obesity in Pregnancy (Green-top Guideline No. 72) Published: 22/11/2018

Type:

Guidance (Add filter)

Source:

Royal College of Obstetricians and Gynaecologists - RCOG (Remove filter)

27 September 2018

Back to guidelines homepage Vasa Praevia: Diagnosis and Management (Green-top Guideline 27b) Published: 27/09/2018

Type:

Guidance (Add filter)